Literature DB >> 8031393

Base modification pattern at the wobble position of Xenopus selenocysteine tRNA(Sec).

C Sturchler1, A Lescure, G Keith, P Carbon, A Krol.   

Abstract

We examined the base modification pattern of Xenopus tRNA(Sec) using microinjection into Xenopus oocytes, with particular focus on the wobble base U34 at the first position of the anticodon. We found that U34 becomes modified to mcm5U34 (5-methylcarboxymethyluridine) in the oocyte cytoplasm in a rather complex manner. When the tRNA(Sec) gene is injected into Xenopus oocyte nuclei, psi 55 and m1A58 are readily obtained, but not mcm5U34. This will appear only upon cytoplasmic injection of the gene product arising from the first nuclear injection. In contrast, tRNA(Sec) produced by in vitro transcription with T7 RNA polymerase readily acquires i6A37, psi 55, m1A58, and mcm5U34. The latter is obtained after direct nuclear or cytoplasmic injections. It has been reported by others that mcm5Um, a 2'-O-methylated derivative of mcm5U34, also exists in rat and bovine tRNA(Sec). With both the gene product and the in vitro transcript, and using the sensitive RNase T2 assay, we were unable to detect under our conditions the presence of a dinucleotide carrying mcm5Um and that would be therefore refractory to hydrolysis. We showed that the unusual mcm5U acquisition pathway does not result from impairment of nucleocytoplasmic transport. Rather, these data can be interpreted to mean that the modification is performed by a tRNA(Sec) specific enzyme, limiting in the oocyte cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031393      PMCID: PMC307989          DOI: 10.1093/nar/22.8.1354

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Use of in vitro 32P labeling in the sequence analysis of nonradioactive tRNAs.

Authors:  M Silberklang; A M Gillum; U L RajBhandary
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Unique pathway of expression of an opal suppressor phosphoserine tRNA.

Authors:  B J Lee; P de la Peña; J A Tobian; M Zasloff; D Hatfield
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

3.  Effect of uridine dethiolation in the anticodon triplet of tRNA(Glu) on its association with tRNA(Phe).

Authors:  C Houssier; P Degée; K Nicoghosian; H Grosjean
Journal:  J Biomol Struct Dyn       Date:  1988-06

4.  Point mutations 5' to the tRNA selenocysteine TATA box alter RNA polymerase III transcription by affecting the binding of TBP.

Authors:  E Myslinski; C Schuster; J Huet; A Sentenac; A Krol; P Carbon
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

5.  Differential accumulation of U1 and U4 small nuclear RNAs during Xenopus development.

Authors:  E Lund; J E Dahlberg
Journal:  Genes Dev       Date:  1987-03       Impact factor: 11.361

6.  Identification of a selenocysteyl-tRNA(Ser) in mammalian cells that recognizes the nonsense codon, UGA.

Authors:  B J Lee; P J Worland; J N Davis; T C Stadtman; D L Hatfield
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

7.  The selenocysteine-inserting opal suppressor serine tRNA from E. coli is highly unusual in structure and modification.

Authors:  A Schön; A Böck; G Ott; M Sprinzl; D Söll
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

8.  Transcription of Xenopus selenocysteine tRNA Ser (formerly designated opal suppressor phosphoserine tRNA) gene is directed by multiple 5'-extragenic regulatory elements.

Authors:  B J Lee; S G Kang; D Hatfield
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

9.  In vitro synthesis of vertebrate U1 snRNA.

Authors:  E Lund; J E Dahlberg
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

10.  Enzymatic 2'-O-methylation of the wobble nucleoside of eukaryotic tRNAPhe: specificity depends on structural elements outside the anticodon loop.

Authors:  L Droogmans; E Haumont; S de Henau; H Grosjean
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more
  7 in total

1.  Methylation of the ribosyl moiety at position 34 of selenocysteine tRNA[Ser]Sec is governed by both primary and tertiary structure.

Authors:  L K Kim; T Matsufuji; S Matsufuji; B A Carlson; S S Kim; D L Hatfield; B J Lee
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

Review 2.  Selenoproteins: molecular pathways and physiological roles.

Authors:  Vyacheslav M Labunskyy; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

3.  Cloning, structural analysis and mapping of the mouse selenocysteine tRNA([Ser]Sec) gene (Trsp).

Authors:  M R Bösl; M F Seldin; S Nishimura; M Taketo
Journal:  Mol Gen Genet       Date:  1995-08-21

4.  Insights into molecular plasticity in protein complexes from Trm9-Trm112 tRNA modifying enzyme crystal structure.

Authors:  Juliette Létoquart; Nhan van Tran; Vonny Caroline; Alexey Aleksandrov; Noureddine Lazar; Herman van Tilbeurgh; Dominique Liger; Marc Graille
Journal:  Nucleic Acids Res       Date:  2015-10-04       Impact factor: 16.971

5.  The Effect of tRNA[Ser]Sec Isopentenylation on Selenoprotein Expression.

Authors:  Noelia Fradejas-Villar; Simon Bohleber; Wenchao Zhao; Uschi Reuter; Annika Kotter; Mark Helm; Rainer Knoll; Robert McFarland; Robert W Taylor; Yufeng Mo; Kenjyo Miyauchi; Yuriko Sakaguchi; Tsutomu Suzuki; Ulrich Schweizer
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 6.208

6.  Regulation of A-to-I RNA editing and stop codon recoding to control selenoprotein expression during skeletal myogenesis.

Authors:  Yuta Noda; Shunpei Okada; Tsutomu Suzuki
Journal:  Nat Commun       Date:  2022-05-06       Impact factor: 17.694

7.  Crystal structure of human selenocysteine tRNA.

Authors:  Yuzuru Itoh; Shiho Chiba; Shun-Ichi Sekine; Shigeyuki Yokoyama
Journal:  Nucleic Acids Res       Date:  2009-08-19       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.